Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to -$321.9 million.

  • Select Medical Holdings' Income towards Parent Company fell 61779.68% to -$321.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$321.9 million, marking a year-over-year decrease of 22826.2%. This contributed to the annual value of -$82.2 million for FY2024, which is 38956.62% down from last year.
  • Select Medical Holdings' Income towards Parent Company amounted to -$321.9 million in Q3 2025, which was down 61779.68% from -$323.7 million recorded in Q2 2025.
  • Select Medical Holdings' Income towards Parent Company's 5-year high stood at $196.2 million during Q2 2021, with a 5-year trough of -$323.7 million in Q2 2025.
  • Moreover, its 5-year median value for Income towards Parent Company was $55.9 million (2022), whereas its average is -$32.0 million.
  • As far as peak fluctuations go, Select Medical Holdings' Income towards Parent Company surged by 19073.88% in 2021, and later tumbled by 61779.68% in 2025.
  • Select Medical Holdings' Income towards Parent Company (Quarter) stood at $66.3 million in 2021, then tumbled by 313.8% to -$141.8 million in 2022, then tumbled by 60.73% to -$227.9 million in 2023, then fell by 27.86% to -$291.4 million in 2024, then dropped by 10.49% to -$321.9 million in 2025.
  • Its last three reported values are -$321.9 million in Q3 2025, -$323.7 million for Q2 2025, and -$317.6 million during Q1 2025.